Cargando…
Alzheimer's Disease, Oestrogen and Mitochondria: an Ambiguous Relationship
Hormonal deficit in post-menopausal women has been proposed to be one risk factor in Alzheimer's disease (AD) since two thirds of AD patients are women. However, large treatment trials showed negative effects of long-term treatment with oestrogens in older women. Thus, oestrogen treatment after...
Autores principales: | Grimm, Amandine, Lim, Yun-An, Mensah-Nyagan, Ayikoe Guy, Götz, Jürgen, Eckert, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Humana Press Inc
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443477/ https://www.ncbi.nlm.nih.gov/pubmed/22678467 http://dx.doi.org/10.1007/s12035-012-8281-x |
Ejemplares similares
-
Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau protein
por: Grimm, Amandine, et al.
Publicado: (2015) -
Inhibition of the Mitochondrial Enzyme ABAD Restores the Amyloid-β-Mediated Deregulation of Estradiol
por: Lim, Yun-An, et al.
Publicado: (2011) -
A proposed preventive role for Gamma-hydroxybutyrate (Xyrem(R)) in Alzheimer’s disease
por: Maitre, Michel, et al.
Publicado: (2016) -
Myelin in Alzheimer’s disease: culprit or bystander?
por: Maitre, Michel, et al.
Publicado: (2023) -
5-HIAA induces neprilysin to ameliorate pathophysiology and symptoms in a mouse model for Alzheimer’s disease
por: Klein, Christian, et al.
Publicado: (2018)